Spinal Metastasis

Modern Study Review (AI-Generated)

High-Yield Summary

Spinal metastasis is a common and clinically significant manifestation of systemic cancer, frequently involving the thoracic and lumbar vertebrae due to the rich vertebral venous plexus (Batson’s plexus). The primary goals in management are pain control, preservation or restoration of neurological function, and spinal stability. Prognostication and treatment decisions rely on validated scoring systems such as the Tokuhashi score, combined with radiographic assessment of spinal stability and neurological status. Radiotherapy remains the cornerstone of treatment, with surgery reserved for selected cases with neurological compromise, mechanical instability, or failure of non-operative management.

Key Diagnostic Findings

Anatomy

• Axial skeleton is the third most common site of metastasis after lung and liver.
• Vertebral bodies have abundant bone marrow and a rich capillary network.
• The vertebral venous plexus (Batson’s plexus) allows hematogenous spread bypassing the lungs.
• Common primary tumors: breast, lung, prostate, hematopoietic malignancies.

Clinical Presentation

• Localized spinal pain (often mechanical).
• Neurological deficits due to spinal cord or nerve root compression (weakness, sensory changes, sphincter dysfunction).
• Signs of spinal instability (progressive deformity, pain with movement).

Imaging

• MRI is the gold standard for detecting spinal cord compression, tumor extent, and soft tissue involvement.
• CT is useful for assessing bony destruction and stability.
• Plain radiographs have limited sensitivity but may show vertebral collapse or pathological fractures.
• Bone scan/PET for systemic disease burden.

Classification Systems

Current Gold Standard Treatment

Non-operative Treatment

• Radiotherapy remains the mainstay for pain control and local tumor control.
• Systemic therapy (chemotherapy, hormonal therapy, targeted agents) tailored to primary tumor type.
• Bisphosphonates/Denosumab to reduce skeletal-related events.
• Pain management with analgesics and corticosteroids to reduce edema.

Operative Indications and Treatment

• Indications:
• Progressive or severe neurological deficits (cord compression).
• Mechanical instability or impending vertebral collapse (based on Taneichi criteria).
• Failure of non-operative management with persistent pain or neurological deterioration.
• Life expectancy >3-6 months (based on prognostic scores like Tokuhashi).

• Surgical options:
• Decompression (laminectomy, corpectomy) to relieve neural elements.
• Stabilization with instrumentation (posterior pedicle screws, anterior reconstruction) to restore spinal stability.
• Minimally invasive approaches increasingly used to reduce morbidity.

Modern Complications & Outcomes

Complications

Outcomes

• Pain relief achieved in >70% with radiotherapy and/or surgery.
• Neurological improvement depends on preoperative status and timing of intervention.
• Spinal stability restoration improves quality of life and mobility.
• Median survival varies widely by primary tumor and systemic disease burden; Tokuhashi score remains a key prognostic tool.
• Multidisciplinary care optimizes functional outcomes and survival.

Classic Clinical Notes

Spinal Metastasis

• The axial skeleton is the third most common site of metastasis after the lung and liver. The spine has much bone marrow with a rich capillary network, and a vertebral venous plexus that does not pass through the lungs (Batson’s plexus). Most common primaries are breast, lung, prostate, and those of hematopoietic origin.

• Radiotherapy remains the mainstay of treatment.

Who do you operate on?

• General indications – neurology, stability, failure of medical management.

What about stability?

• Taneichi H. Et al. Risk Factors and Probability of Vertebral Body Collapse in metastases of the Thoracic and Lumbar Spine, Spine, 22(3), 239-245, 1997.

• Attempted to predict vertebral collapse secondary to metastatic disease. Looked at the percentage of tumour occupancy in the body, pedicular involvement, posterior element involvement, and involvement of the costovertebral joint.

• In the lumbar spine, the most important factors for collapse were percentage of tumour occupancy and pedicle destruction. Impending collapse was predicted if 35-40% of the vertebral body was involved alone, or if 20-25% of the body was involved with associated involvement of the posterior elements including the pedicles.

• In the thoracic spine, the most important factors were costovertebral joint involvement and percentage of tumour occupancy. Impending collapse was predicted if 50-60% of the vertebral body was involved alone, or if 25-30% of the body was involved with associated involvement of the costovertebral joint.

What about life expectancy?

• Enkaoua E.A. et al. Vertebral Metastases. A Critical Appreciation of the Preoperative Prognostic Tokuhashi Score in a Series of 71 Cases. Spine. 22(10) 2293-2298, 1997.

• Attempted to validate Tokuhashi’s scoring prognosticating system in 71 cases – 37 thyroid, 29 renal, 19 unknown primary. The score is composed of six items – general condition, number of extraspinal bone mets, number of vertebral body mets, mets in major internal organs, primary site, and presence of cord involvement. The score is calculated preoperatively, for a maximum possible 12 points.

• In patients with a score of seven or less, median survival was only 5.3 months. In those with a score of 8 or more, the median survival was 23.6 months.

Tokuhashi’s Evaluation System

Authors felt that unidentified primary portended an extremely poor prognosis and would be better scored a 0 rather than a 1.

Last Updated on January 25, 2026 by orthonet